IBB was created on 2001-02-05 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 8023.29m in AUM and 248 holdings. IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.